Genetic characterization of antithrombin, protein C, and protein S deficiencies in Polish patients

Polish Archives of Internal Medicine

Volumn 127 127, Issue 7-8, 2017, Pages 512-523

  Wypasek, Ewa ^a,b   Corral, Javier ^c   Alhenc gelas, Martine ^d   Sydor, Wojciech ^b   Iwaniec, Teresa ^b   Celinska lowenhoff, Magdalena ^b   Potaczek, Daniel P ^a,e   Blecharczyk, Aleksandra ^a   Zawilska, Krystyna ^f   Musial, Jacek ^b   Undas, Anetta ^a,b  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c UNIVERSITY OF MURCIA   (Spain)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antithrombin; Polish patients; Protein c; Protein s; Venous thromboembolism

Indexed keywords

ANTITHROMBIN; PROTEIN C; PROTEIN S; ANTITHROMBIN III; PLASMA PROTEIN; PROS1 PROTEIN, HUMAN; SERPINC1 PROTEIN, HUMAN;

ADULT; AGE; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTERIAL THROMBOEMBOLISM; ARTICLE; COHORT ANALYSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NONSENSE MUTATION; POLAND; PROC GENE; PROS1 GENE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SANGER SEQUENCING; SERPINC1 GENE; SPLICE SITE MUTATION; VENOUS THROMBOEMBOLISM; ADOLESCENT; AGED; BLOOD PROTEIN DISORDER; DNA MUTATIONAL ANALYSIS; GENETICS; MIDDLE AGED; MUTATION; YOUNG ADULT; ARTERY THROMBOSIS; CONTROLLED STUDY; EXON; GENETIC ANALYSIS; GENETIC BACKGROUND; GENETIC DISORDER; GENETIC VARIABILITY; INTRON; POLISH CITIZEN; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; BLOOD PROTEIN DISORDERS; BLOOD PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; POLAND; PROTEIN C; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; YOUNG ADULT;

EID: 85027411271     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.4045     Document Type: Article

References (47)

1. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haemotol. 1994; 87: 106-112.
2. Whitlatch NL, Ortel TL. Thrombophilias: When should we test and how does it help? Semin Respir Crit Care Med. 2008; 29: 25-39.
3. García de Frutos P, Fuentes-Prior P, Hurtado B, et al. Molecular basis of protein S deficiency. Thromb Haemost. 2007; 98: 543-556.
4. Douketis J, Ageno W, Carrier M, et al. Managing challenging patients with venous thromboembolism: A practical, case-based approach. Pol Arch Intern Med. 2017; 1:41-46.
5. Weitz JI, Jaffer IH. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants. Pol Arch Med Wewn. 2016; 9: 688-696.
6. Di Minno MN, Ambrosino P, Ageno W, et al. Natural anticoagulants deficiency and the risk of venous thromboembolism: A meta-Analysis of observational studies. Thromb Res. 2015; 5: 923-932.
7. Heit JA. Epidemiology of venous thromboembolism Nat Rev Cardiol. 2015; 8: 464-474.
8. Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: Results from a large family cohort study. Circulation. 2008; 118: 1659-1667.
9. Sayin MR, Akpinar I, Karabag T, et al. Left main coronary artery thrombus resulting from combined protein C and S deficiency. Intern Med. 2012; 51: 3041-3044.
10. Patnaik M, Moll S. Inherited antithrombin deficiency: A review. Haemophilia. 2008; 14: 1229-1239.
11. Dahlbäck B, Villoutreix BO. Molecular recognition in the protein C anticoagulant pathway. J Thromb Haemost. 2003; 1: 1525-1534.
12. Dahlbäck B. Inhibition of protein C cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986; 261: 12022-12027.
13. Maurissen LFA, Thomassen MC, Nicolaes GAF, et al. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood. 2008; 111: 3034-3041.
14. Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci U S A. 1985; 82: 4673-4677.
15. Schmidel DK, Tatro AV, Phelps LG. Organization of the human protein S genes. Biochemistry. 1990; 29: 7845-7852.
16. Caspers M, Pavlova A, Driesen J, et al. Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort. Thromb Haemost. 2012; 2: 247-257.
17. Odnoczko E, Vertun-Baranowska B, Buczma A, et al. [Genetic analysis of inherited antithrombin deficiency in 18 Polish families]. Acta Haematol Pol. 2011; 42: 519-524. Polish.
18. Celinska-Lowenhoff M, Iwaniec T, Alhenc-Gelas M, et al. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow). Thromb Haemost. 2011; 2: 379-381.
19. Wypasek E, Pankiw-Bembenek O, Potaczek DP, et al. A missense mutation G109R in the PROC gene associated with type I protein C deficiency in a young Polish man with acute myocardial infarction. Int J Cardiol. 2013; 5: 46-48.
20. Wypasek E, Alhenc-Gelas M, Undas A. First report of a large PROS1 deletion from exon 1 through 12 detected in Polish patients with deep-vein thrombosis. Thromb Res. 2013; 1: 143-144.
21. Taylor J. Third universal definition of myocardial infarction. Eur Heart J. 2012; 20: 2506-2507.
22. Wypasek E, Undas A. Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med. 2013; 4: 459-467.
23. Undas A, Góralczyk T. Direct oral anticoagulants in patients with thrombophilia: challenges in diagnostic evaluation and treatment. Adv Clin Exp Med. 2016; 6: 1321-1330.
24. Lane DA, Kunz G, Olds RJ, et al. Molecular genetics of antithrombin deficiency. Blood Rev. 1996; 10: 59-74.
25. Bereczky Z, Kovács KB, Muszbek L. Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game. Clin Chem Lab Med. 2010; 48: 53-66.
26. de la Morena-Barrio M, Sandoval E, Llamas P, et al. High levels of latent antithrombin in plasma from patients with antithrombin deficiency. Thromb Haemost. 2017; 2017; 117: 880-888.
27. Alhenc-Gelas M, Gandrille S, Aubry ML, et al. Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein S. Thromb Haemost. 2000; 83: 86-92.
28. Alhenc Gelas M, Juin F, de Raucourt E, et al. Influence of PROS1 gene mutations affecting protein S amino-Acid 275 on plasma free protein S measurement. Thromb Haemost. 2007; 97: 678-680.
29. de la Morena-Barrio ME, Sevivas TS, Martinez-Martinez I, et al. Congenital disorder of glycosylation (PMM2-CDG) in a patient with antithrombin deficiency and severe thrombophilia. J Thromb Haemost. 2012; 12: 2625-2627.
30. Corral J, Huntington JA, Gonzalez-Conejero R, et al. Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis. J Thromb Haemost. 2004; 6: 931-939.
31. Picard V, Dautzenberg MD, Villoutreix BO, et al. Antithrombin F229L: A new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis. Blood. 2003; 102: 919-925.
32. Fitches AC, Lewandowski K, Olds RJ. Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency. Thromb Haemost. 2001; 4:1023-1027.
33. Tang L, Guo T, Yang R, et al. Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population. PLoS One. 2012; 4: E35773.
34. Preston RJ, Ajzner E, Razzari C et al. Multifunctional specificity of the protein C/activated protein C Gla domain. J Biol Chem. 2006; 39: 28850-28857.
35. Kuismanen K, Levo A, Vahtera E, et al. Genetic background of type I protein C deficiency in Finland. Thromb Res. 2006; 5: 603-609.
36. Vincenot A, Gaussem P, Pittet JL, et al. Amino acids 225-235∗∗ of the protein C serine-protease domain are important for the interaction with the thrombin-thrombomodulin complex. FEBS Lett. 1995; 2: 153-157.
37. Soria JM, Brito D, Barceló J, et al. Severe homozygous protein C deficiency: identification of a splice site missense mutation (184, Q->H) in exon 7 of the protein C gene. Thromb Haemost. 1994; 1: 65-69.
38. Rovida E, Merati G, D'Ursi P, et al. Identification and computationally-based structural interpretation of naturally occurring variants of human protein C. Hum Mutat. 2007; 4: 345-355.
39. Wypasek E, Potaczek DP, Alhenc-Gelas M, et al. Novel missense mutation C106R in the PROC gene associated with type I protein C deficiency in a young Polish man with high-risk pulmonary embolism. Pol Arch Med Wewn. 2014; 1-2: 75-76.
40. Stenberg Y, Linse S, Drakenberg T, et al. The high affinity calcium-binding sites in the epidermal growth factor module region of vitamin K-dependent protein S. J Biol Chem. 1997; 37: 23255-23260.
41. van de Poel RH, Meijers JC, Bouma BN. The interaction between anticoagulant protein S and complement regulatory C4b-binding protein (C4BP). Trends Cardiovasc Med. 2000; 2: 71-76.
42. Almasy L, Soria JM, Souto JC, et al. A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q: Results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) project. Arterioscler Thromb Vasc Biol. 2003; 23: 508-511.
43. Buil A, Soria JM, Souto JC, et al. Protein C levels are regulated by a quantitative trait locus on chromosome 16: Results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Arterioscler Thromb Vasc Biol. 2004; 24: 1321-1325.
44. Medina P, Navarro S, Bonet E, et al. Functional analysis of two haplotypes of the human endothelial protein C receptor gene. Arterioscler Thromb Vasc Biol. 2014; 3: 684-690.
45. Kimura R, Kokubo Y, Miyashita K, et al. Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population. Int J Hematol. 2006; 84: 387-397.
46. Ungerstedt JS, Schulman S, Egberg N, et al. Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients? Blood. 2002; 6: 2271-2272.
47. Khor B, Van Cott EM. Laboratory tests for antithrombin deficiency. Am J Hematol. 2010; 85: 947-950.